Close Menu

NEW YORK – A research team from the US and Spain has identified distinct immune responses, viral load features, and other differences in infants and young children who experience more severe respiratory syncytial virus (RSV) infections.

Overall, the results "suggest that robust innate immune responses are associated with mild RSV infection in infants," co-corresponding authors Asuncion Mejias and Octavio Ramilo, with the Research Institute at Nationwide Children's Hospital Center for Vaccines and Immunity, and their colleagues reported.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.